Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Evonik
Sort By
Newest First
1 / 2
1 / 2
Changing Roles
How are Advancements in Technology Reshaping the Roles and Capabilities of CDMOs and CROs in the Drug Development Life Cycle?
Pharma's Almanac
PAO-08-24-RT-01
Aug 07, 2024
Global Access
How Can (Bio)pharmaceutical Companies Contribute to Improving Global Access to Essential Medications?
Pharma's Almanac
PAO-08-24-RT-02
Aug 07, 2024
Commitment to ESG Principles
How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?
Pharma's Almanac
PAO-03-24-CL-03
Mar 08, 2024
Accelerating Product Development
What strategies are being employed to accelerate product development and commercialization without compromising quality?
Pharma's Almanac
PAO-03-24-CL-02
Mar 08, 2024
Roundtable
What do you see as the most significant regulatory decision or guidance on the horizon for 2024 (or beyond)?
Pharma's Almanac
PAO-12-23-RT-02
Dec 15, 2023
Roundtable
What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023?
Pharma's Almanac
PAO-12-23-RT-01
Dec 14, 2023
International Markets
In what international markets do you anticipate significant developments in the near future?
Pharma's Almanac
PAO-01-23-RT-02
Jan 31, 2023
Disruptive Technology
What do you view as the most disruptive or transformational technology or development on the horizon?
Pharma's Almanac
PAO-01-23-RT-01
Jan 31, 2023
Custom Lipid Nanoparticle Development
The Value of a Custom Lipid Solutions Provider for mRNA Delivery
Lauren Longobardi, Ph.D.; Rima Jaber, Ph.D.; Sebastian Detlefsen, Dr.-Ing.
Evonik
PAO-11-022-CL-17
Jan 05, 2023
Future of the Industry
What key indicators do you look at to predict the future of this industry?
Pharma's Almanac
PAO-10-022--RT-02
Oct 11, 2022
Sustainability
What is your plan to build a more sustainable business practice in the coming years?
Pharma's Almanac
PAO-10-022--RT-01
Oct 11, 2022
mRNA Delivery
New Polymer-Lipid Delivery System for mRNA
Andrea Engel, Ph.D.; Philipp Heller, Ph.D.
Evonik
PAO-05-022-CL-09
May 31, 2022
Leadership
Q: What’s the key to being a leader in the industry?
Pharma's Almanac
PAO-03-022-RT-02
Mar 11, 2022
Milestones
Q: What important company milestone do you anticipate reaching in 2022?
Pharma's Almanac
PAO-03-022-RT-01
Mar 11, 2022
Parenteral Drug Delivery
Innovating at the Forefront of mRNA LNP Therapies
Evonik
PAO-02-22-R250-08
Feb 10, 2022
Personalized and Precision Medicine
Q: What do you see as the key innovations or technologies that will make personalized/precision medicine a reality?
Pharma's Almanac
PAO-12-21-RT-01
Jan 07, 2022
Therapeutic Progress
Q: For what therapeutic area do you think we will see the greatest progress in the coming years?
Pharma's Almanac
PAO-12-21-RT-02
Jan 07, 2022
Lipid Nanoparticles
Leveraging True Expertise and Flexibility for Lipid Nanoparticle Clinical Manufacturing
Cole Byvelds, P.Eng.; Kristina Parrant
Evonik
PA656
Dec 14, 2021
Parenteral Manufacturing
Focus on Commercial Parenteral Manufacturing at Evonik
Caroline Hand; Maaike Everts, Ph.D.
Evonik
PAO-09-21-CL-15
Oct 08, 2021
Lipid Nanoparticles
Advancing Novel Therapeutics with End-to-End Lipid Nanoparticle Development and Manufacturing
Natalia Zisman
Evonik
PAO-07-21-CL-02
Jul 12, 2021